Monday, November 11, 2019

Breast cancer: An innovative blood test could aid early detection

Researchers are developing a blood test that could help detect breast cancer 5 years before any symptoms become apparent. This method would also be less uncomfortable and more cost effective than traditional mammograms.

Read more here- https://bit.ly/2qKmqw4

Join us at Barcelona to know this new approach. 

 Details on-

breastcancer breastcancerawaness oncology Surgery Cancer Barcelona Europe

Friday, November 1, 2019

How Immunotherapy Is Making an Impact in Breast Cancer?? || join us in Spain



 Breast cancer continues to be a global health crisis. In 2018, there were an estimated 2.1 million new cases of breast cancer worldwide. In the United States alone, another life is lost to breast cancer every 15 minutes. Breast cancer comes in several forms, with triple-negative breast cancer being the most aggressive and hardest to treat. In all subtypes, once the cancer has metastasized, or spread from the breast to other organs, the odds are survival are significantly lower. These advanced breast cancers are also less likely to respond to traditional treatments.

Sources-  https://bit.ly/2r37pWC

Join us at Barcelona to know this new approach. 

 Details on- https://lnkd.in/fNHF3BX

breastcancer breastcancerawaness oncology Surgery Cancer Barcelona Europe

Tuesday, October 15, 2019

Multigene testing for all patients with breast cancer cost-effective, ‘will save more lives


Multigene testing for all patients with breast cancer could be a cost-effective way to reduce disease burden compared with testing based upon family history or other clinical criteria, according to study results.
“Our research strategy is focused on targeted precision prevention, [and] a key theme in our research strategy for a long time has been broadening access to genetic testing. This will increase the number of people who can access prevention and screening and reduce burden of disease well beyond what is possible through current clinical protocols,” Ranjit Manchanda, MD, PhD, clinical senior lecturer at Wolfson Institute of Preventive Medicine of Barts Cancer Institute at Queen Mary University of London, told HemOnc Today. “This has two components and approaches — increasing testing at cancer diagnosis and population testing. The work for this particular paper is providing evidence for testing all [patients with] breast cancer.”

Source-  https://bit.ly/2VSekgN

Contact us on –
 
More details on- https://breastcancer.pulsusconference.com/
 
breastcancer Congress Spain abstract Research Group

Tuesday, October 1, 2019

Breast Cancer 2020 | Spain



In recent years,Researcher have seen remarkable progress in treatment options and improved outcomes for breast cancer patients. 

To know more join us @Barcelona, Spain April 29-30,2020 

More Details- https://bit.ly/2s8xD6O
 
BreastCancerCongress CancerSurvivor Research Spain #Speaker #Conference


Tuesday, August 6, 2019

Radiation Therapy | Breast Cancer 2019

Microbubbles make breast cancer more susceptible to radiation therapy


Bursting oxygen-filled microbubbles in breast cancer makes tumours three times more sensitive to radiation therapy in preliminary tests with animal models of the disease…

Injecting breast cancer with oxygen-filled microbubbles makes tumours three-times more sensitive to radiation therapy and improves survival in animal models of the disease. The study makes a strong case for moving this technology into clinical trials with breast cancer patients. 


More details about congress-   https://bit.ly/2s8xD6O

keynote conference research speaker Scotland cancer September oncology


 

Obstetrics and Gynecology | Paris, France

Gynecologic cancers are treated in several ways. It depends on the kind of cancer and how far it has spread. Treatments include surger...